em 139 has been researched along with bromodeoxyuridine in 1 studies
| Studies (em 139) | Trials (em 139) | Recent Studies (post-2010) (em 139) | Studies (bromodeoxyuridine) | Trials (bromodeoxyuridine) | Recent Studies (post-2010) (bromodeoxyuridine) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 13,164 | 71 | 1,816 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dauvois, S; de Launoit, Y; Dufour, M; Labrie, F; Simard, J | 1 |
1 other study(ies) available for em 139 and bromodeoxyuridine
| Article | Year |
|---|---|
Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer ZR-75
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Humans; Interphase; Tumor Cells, Cultured | 1991 |